Leading Financial Service Provider in India | Canara Bank Securities Ltd

Alkem Laboratories Ltd.

Aug 13, 04:01 BSE 5418.75 ( -51.25 -0.94%)

Volume887

Prev. Close
5470.00

Open Price
5470.05

Today's Low / High

5411.50 5479.05

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

4825.05 5933.00

Aug 13, 03:56 NSE 5449.50( -30.50 -0.56%)

Volume33025

Prev. Close
5480.00

Open Price
5459.00

Today's Low / High

5406.00 5483.00

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.)
5449.50 (20)

52 Wk Low / High

4822.00 5933.50

Market Cap. ( ₹ in Cr. )	65156.95	P/BV	4.71	Book Value ( ₹ )	1,155.87
52 Week High/Low ( ₹ )	5934/4822	FV/ML	2/1	P/E(X)	28.31
Book Closure	07/08/2026	EPS ( ₹ )	192.51	Div Yield (%)	0.97

(₹ in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	2.00
No. of Equity Shares (in Lacs)	1195.65	1195.65	1195.65	1195.65	1195.65

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	23.91	23.91	23.91	23.91	23.91
Total Share Capital	23.91	23.91	23.91	23.91	23.91

Reserves and Surplus	13796.19	11960.96	10268.61	9021.38	8613.99
Total Reserves and Surplus	13796.19	11960.96	10268.61	9021.38	8613.99
Employees Stock Options	0.00	0.00	19.54	0.00	0.00
Total Shareholders Funds	13820.10	11984.87	10312.06	9045.29	8637.90
Minority Interest	528.83	448.76	402.34	389.71	209.43

NON-CURRENT LIABILITIES
Long Term Borrowings	492.45	310.91	40.00	0.00	9.38
Deferred Tax Liabilities [Net]	15.12	0.00	0.00	0.00	0.00
Other Long Term Liabilities	802.56	643.36	526.09	245.14	74.39
Long Term Provisions	431.21	338.22	299.86	369.36	332.75
Total Non-Current Liabilities	1741.34	1292.49	865.95	614.50	416.52

CURRENT LIABILITIES
Short Term Borrowings	1131.05	751.88	1173.97	1307.15	2570.74
Trade Payables	2244.18	1839.35	1748.12	1165.03	1173.38
Other Current Liabilities	1206.82	1214.64	945.59	862.22	787.62
Short Term Provisions	200.65	159.11	126.87	372.75	273.60
Total Current Liabilities	4782.70	3964.98	3994.55	3707.15	4805.34

Total Capital And Liabilities	20872.97	17691.10	15574.90	13756.65	14069.19

ASSETS
NON-CURRENT ASSETS
Tangible Assets	3090.63	2386.15	2408.63	2203.25	2287.10
Intangible Assets	256.76	43.05	47.41	66.41	211.54
Capital Work-In-Progress	137.91	476.55	148.40	310.27	339.48
Intangible Assets Under Development	143.88	71.52	10.17	12.97	0.00
Fixed Assets	3629.18	2977.27	2614.61	2592.90	2838.12
Goodwill On Consolidation	523.64	423.11	416.74	413.17	403.09
Non-Current Investments	1131.50	943.24	334.80	304.61	231.67
Deferred Tax Assets [Net]	1819.35	1738.25	1514.83	1302.50	1309.26
Long Term Loans And Advances	0.00	0.00	0.00	8.02	8.02
Other Non-Current Assets	1558.78	663.41	282.34	405.75	843.60
Total Non-Current Assets	8662.45	6745.28	5163.32	5026.95	5633.76


CURRENT ASSETS
Current Investments	737.31	902.26	148.99	317.21	139.31
Inventories	3333.22	2922.41	2661.18	2607.53	3005.53
Trade Receivables	2979.11	2466.25	2252.81	2132.18	1884.60
Cash And Cash Equivalents	1732.90	1563.08	1579.35	2616.89	2578.58
Short Term Loans And Advances	6.63	9.04	9.07	6.77	20.25
OtherCurrentAssets	3421.35	3082.78	3760.18	1049.12	807.16
Total Current Assets	12210.52	10945.82	10411.58	8729.70	8435.43

Total Assets	20872.97	17691.10	15574.90	13756.65	14069.19

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	1388.50	995.22	210.67	410.26	425.90

BONUS DETAILS
Bonus Equity Share Capital	11.96	11.96	11.96	11.96	11.96

NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	880.36	710.39	170.40	142.67	0.00
Non-Current Investments Unquoted Book Value	251.14	200.47	164.40	161.94	126.59

CURRENT INVESTMENTS
Current Investments Quoted Market Value	662.61	827.56	46.92	212.14	0.00
Current Investments Unquoted Book Value	74.70	74.70	102.07	105.06	0.00

Particulars	Mar 26
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	2.00
No. of Equity Shares (in Lacs)	1195.65

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	23.91
Total Share Capital	23.91
Reserves and Surplus	13796.19
Total Reserves and Surplus	13796.19
Employees Stock Options	0.00
Total Shareholders Funds	13820.10
Minority Interest	528.83
NON-CURRENT LIABILITIES
Long Term Borrowings	492.45
Deferred Tax Liabilities [Net]	15.12
Other Long Term Liabilities	802.56
Long Term Provisions	431.21
Total Non-Current Liabilities	1741.34
CURRENT LIABILITIES
Short Term Borrowings	1131.05
Trade Payables	2244.18
Other Current Liabilities	1206.82
Short Term Provisions	200.65
Total Current Liabilities	4782.70
Total Capital And Liabilities	20872.97
ASSETS
NON-CURRENT ASSETS
Tangible Assets	3090.63
Intangible Assets	256.76
Capital Work-In-Progress	137.91
Intangible Assets Under Development	143.88
Fixed Assets	3629.18
Goodwill On Consolidation	523.64
Non-Current Investments	1131.50
Deferred Tax Assets [Net]	1819.35
Long Term Loans And Advances	0.00
Other Non-Current Assets	1558.78
Total Non-Current Assets	8662.45
CURRENT ASSETS
Current Investments	737.31
Inventories	3333.22
Trade Receivables	2979.11
Cash And Cash Equivalents	1732.90
Short Term Loans And Advances	6.63
OtherCurrentAssets	3421.35
Total Current Assets	12210.52
Total Assets	20872.97
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	1388.50
BONUS DETAILS
Bonus Equity Share Capital	11.96
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	880.36
Non-Current Investments Unquoted Book Value	251.14
CURRENT INVESTMENTS
Current Investments Quoted Market Value	662.61
Current Investments Unquoted Book Value	74.70

Markets

Balance Sheet

BALANCE SHEET

Alkem Laboratories Ltd.